It can take 10-15 years to develop a new medicine at an estimated cost of £1.2bn
At the Medicines Discovery Catapult we aim to help UK SME biotechs, academics and innovators have access to the laboratory facilities, knowledge, data, technologies and networks they need to be able to progress their programmes of medicines research and development. Our objective is to work collaboratively as part of a Syndicate to bring new proven therapies to patients faster and more cost-effectively.
Latest News
Cheshire East Council welcomes funding for Validation Centre of Excellence at Alderley Park
Cheshire East Council has welcomed the announcement on 4 August 2020, of £15.5 million of the Getting Building Fund for investment in schemes in Cheshire
Alderley Park Lighthouse Laboratory processes 1 million samples
The Alderley Park Lighthouse Lab, which was launched to rapidly expand COVID-19 testing capacity, has processed more than 1 million test samples since opening. The
What makes a drug discovery consortium successful? Our scientists discuss in Nature Reviews Drug Discovery
Consortia are enabling drug discovery in areas that individual organizations are unable to support alone because of the high risk or the need to pool